Skip to main content
Contact Us
Subscribe
E-Edition
53°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
264.49
+0.49 (+0.19%)
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amgen
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
48
49
Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Amgen
November 18, 2022
Via
Benzinga
2 Stocks to Buy Whether or Not a Recession Is Coming
November 18, 2022
Both have outperformed the stock market this year.
Via
The Motley Fool
Where Amgen Stands With Analysts
November 18, 2022
Via
Benzinga
7 Top-Tier Dividend Stocks to Buy for 2023
November 18, 2022
You can find great top-tier dividend stocks in a variety of sectors. These are some of the best names you can buy heading into 2023.
Via
InvestorPlace
Amgen Earnings Perspective: Return On Invested Capital
November 17, 2022
Via
Benzinga
2 Ultra-Safe Passive Income Stocks to Buy Right Now
November 10, 2022
These two top biopharma stocks are crushing the 2022 bear market.
Via
The Motley Fool
Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts
November 03, 2022
The company offered a stronger-than-expected guidance boost for the year.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
How Is The Market Feeling About Amgen?
November 15, 2022
Amgen's (NASDAQ:AMGN) short percent of float has fallen 29.84% since its last report. The company recently reported that it has 11.77 million shares sold short, which is 2.21% of all regular shares...
Via
Benzinga
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
November 15, 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 15, 2022 – USA News Group – Roughly five years after selling its flagship cancer asset Onivyde from to French biotech...
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
Analyst Ratings for Amgen
October 31, 2022
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 6 Analyst Ratings Have To Say About Amgen
October 31, 2022
Amgen (NASDAQ:AMGN) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
Learn More about Organicell Regenerative Medicine, Inc. by gaining access to the latest research report In the medical community, the popularity of regenerative medicine is reportedly soaring primarily...
Via
Benzinga
This US Representative Just Bought Shares Of Airbnb And These 2 Dividend-Paying Stocks
November 12, 2022
Congressman Josh Gottheimer (D-NJ) has made over 1,200 trades in the past three years, with his top two traded stocks being Microsoft (NASDAQ: MSFT) and Apple (NASDAQ: AAPL), reported b
Via
Benzinga
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review
November 11, 2022
Bitcoin hit a two-year low while Meta and Tesla were in focus.
Via
Investor's Business Daily
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
November 11, 2022
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.
Via
MarketBeat
Market Briefing For Wednesday, Nov. 9
November 09, 2022
For the moment, S&P should attempt yet-another trust, react to the CPI just a day later and then possibly go on the defensive, but not for a catastrophe.
Via
Talk Markets
Dow Logs Highest Close Since Late August
November 08, 2022
The Dow stayed hot today, nabbing its third-straight win on the back of a 333-point gain.
Via
Talk Markets
How Amgen Is Closing In On Rivals Novo Nordisk, Eli Lilly With Obesity Drug
November 08, 2022
Early-stage results look promising for Amgen's experimental obesity treatment.
Via
Investor's Business Daily
Amgen's Olpasiran Reduced Cholesterol Levels In 95% Of Patients In Mid-Stage Study
November 07, 2022
Amgen Inc (NASDAQ: AMGN) presented end-of-treatment data from its Phase 2 OCEAN(a)-DOSE study of olpasiran (formerly AMG 890) in adults with elevated lipoprotein levels and a history of atherosclerotic...
Via
Benzinga
Musk Reportedly Suspends Twitter Work On Crypto Wallet, Boeing's Jeppesen Hit By Potential Ransomware Attack, Lyft Cuts Workforce: Top Stories Friday, Nov. 04
November 04, 2022
Reuters
Via
Benzinga
Amgen Reports Q3 Higher Profit, Despite Slight Fall In Topline Growth
November 04, 2022
Via
Benzinga
2 Dividend Stocks to Hold Through a Recession and Beyond
November 03, 2022
If a recession does come, it won't be the first that these two companies will have survived one.
Via
The Motley Fool
Looking At Amgen's Recent Unusual Options Activity
November 02, 2022
Someone with a lot of money to spend has taken a bullish stance on Amgen (NASDAQ:AMGN). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
October 31, 2022
The competition between pharmaceutical company trials to help the 2% to 3% of the population suffering from chronic psoriasis is heating up.
Via
TheNewswire.com
Exposures
Product Safety
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
October 31, 2022
By Mark Gilman, Benzinga
Via
News Direct
Exposures
Product Safety
Dogs Of The Dow: A Leading Strategy In 2022
October 30, 2022
At that time the Dow Dogs strategy had a positive year-to-date return versus the negative return of the Dow Jones Industrial Average Index and the S&P 500 Index.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
Could Amgen Continue To Soar In This Bear Market?
October 28, 2022
Amgen did a mini pull back then broke out on 24 Oct and committed above $260. According to the Wyckoff trading method, there is no immediate threatening supply hence the price could continue to climb...
Via
Talk Markets
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
48
49
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.